Biotechnology Businesses for Sale and Investment

The company is selling perpetual usage rights of an AI platform that analyzes microbiome and health data to deliver personalized nutrition and wellness plans. - Partners can deploy and white-label the platform locally, offering premium, data-driven health solutions under their own brand. - The sale includes the proprietary core AI algorithms and source code for the microbiome-based precision diet technology. - Partners receive the right to unlimited API access and the ability to customize and train the AI with local data, ensuring relevance and effectiveness in their market. - The license also grants the right to localized deployment on the partner's local servers for compliance and security, and the autonomy to operate and brand the AI as their own. - The capacity of the AI model is virtually unlimited as it is scalable to the partner's server infrastructure, and its condition is excellent, being actively maintained by us. - The tangible assets required for the operation are minimal and fall primarily under the partner's operational responsibility, reflecting a lean, software-driven business model. - The partner is responsible for managing the inventory of sample collection kits (optional cost of GBP 7.5 per kit), requiring only a small fulfillment/warehouse space for storage and shipping. - We have successfully validated our technology on a global scale, processing over 50,000 microbiome samples across 15+ countries and securing strategic partnerships with major industry players. - Our deep-tech innovation has been recognized with prestigious global awards, including the UK Tech Rocketship Award and victories in the Sanofi and Bayer accelerator programs, establishing us as a trusted leader in the personalized health sector. - The business is driven by a seasoned leadership team, including a serial entrepreneur CEO and a CTO with 15+ years of bioinformatics expertise, ensuring clinical validity and robust architecture. - You can establish a high-margin, end-to-end health service by integrating our software with local Next-Generation Sequencing (NGS) laboratories. - In this model, our partner manages the complete value chain: collecting biological samples, processing them locally, and utilizing our AI to generate premium precision diet and health reports. - These complete diagnostic packages are then sold directly to consumers, medical clinics, and hospitals, allowing the partner to capture the full market value of every test performed. - Alternatively, you can leverage your exclusive regional rights to create a scalable B2B sublicensing ecosystem. - Acting as a master distributor, one can sublicense the software access to other local laboratories, wellness apps, and healthcare networks within the territory. - This allows to generate significant recurring revenue by charging own clients for API access or white-labeled portals, effectively monetizing the technology across the entire region without needing to manage every sample personally. - The company is headquartered in London, while the promoter is currently based in the US and has provided that number for all communications.

Client base: Served a wide range of B2B and B2C clients, including corporates, institutions, and individual customers during the COVID-19 period through sanitizer supply. - Currently working with multiple researchers, organizations, and academic institutions for product formulation, outsourcing works, and collaborative projects. - Revenue model: Product sales – Revenue from biotech-based products (e. g. , sanitizers, organic formulations). Services – Income from outsourcing works, product formulation contracts, and collaborative R&D. Training & projects – Fees from student training programs and academic project guidance in biotechnology and life sciences. We get about INR 3-6 lakh of monthly revenue from the services mentioned above. - Promoter experience: The business is led by promoters with strong academic and professional backgrounds in biotechnology research, product development, and laboratory management, with proven expertise in collaborations and student mentorship. - Business relationships: Established strong collaborations with researchers, universities, and organizations for outsourcing projects, technology development, and training initiatives. - Business has a certificate of incorporation and GST certificate. - Awards & Recognition: Mockingjay Award. IVAEX Women’s Day Award. Recognized for contributions during COVID-19 through large-scale sanitizer supply. Appreciated by academic institutions for providing consistent training and project opportunities to students.

Client base: Served a wide range of B2B and B2C clients, including corporates, institutions, and individual customers during the COVID-19 period through sanitizer supply. - Currently working with multiple researchers, organizations, and academic institutions for product formulation, outsourcing works, and collaborative projects. - Revenue model: Product sales – Revenue from biotech-based products (e. g. , sanitizers, organic formulations). Services – Income from outsourcing works, product formulation contracts, and collaborative R&D. Training & projects – Fees from student training programs and academic project guidance in biotechnology and life sciences. We get about INR 3-6 lakh of monthly revenue from the services mentioned above. - Promoter experience: The business is led by promoters with strong academic and professional backgrounds in biotechnology research, product development, and laboratory management, with proven expertise in collaborations and student mentorship. - Business relationships: Established strong collaborations with researchers, universities, and organizations for outsourcing projects, technology development, and training initiatives. - Business has a certificate of incorporation and GST certificate. - Awards & Recognition: Mockingjay Award. IVAEX Women’s Day Award. Recognized for contributions during COVID-19 through large-scale sanitizer supply. Appreciated by academic institutions for providing consistent training and project opportunities to students.

Company: 25-year-old bio-diagnostics manufacturer based in Amman, Jordan, specializing in in vitro diagnostic reagents and medical lab reagent kits. - Workforce & scale: 63 employees operating US FDA- and CE-certified production and quality-control facilities. - Product line: Reagents and complete diagnostic kits used to measure analytes in human blood, urine, and stool for clinical chemistry and medical laboratories. - Production capacity: Able to produce 6,000 vials/day or ~1,000 kits/day, nominally ~24,000 kits/month at regular shifts; with overtime reaches ~30,000–35,000 kits/month. - Market coverage: Export-focused business selling to ~90 countries via dealer network; active dealers in 70+ countries across the USA, LATAM, Europe (strong in Germany and other EU markets), MENA (notably KSA), West Asia, Southeast Asia, Africa, and the Americas. - Customer profile: Primary customers are small-to-medium medical labs and diagnostic centers that consume 50–60% of the company’s routine reagent portfolio. Dealers/distributors serve larger regional purchasing and logistics. - Competitive strengths: Regulatory certifications (USFDA, CE), long industry track record, broad geographic distribution, and capacity to scale production to meet rising lab reagent demand. - Sales channels & monetization: Revenue generated through wholesale sales to dealers, direct bulk orders from clinical labs, and repeat sales of consumable reagents and diagnostic kits (recurring revenue from per-test consumables). - Monthly revenue depends on the number and size of orders, not on the number of employees.

Located in Bangalore, this biotechnology and microbiology research and training organization specializes in training students and conducting small-scale research and development (R&D) production. - The organization provides hands-on training in biotechnology, microbiology, and DNA/RNA extraction, attracting students, PhD scholars, and startup companies. - Additionally, we offer essential food and water testing services to a diverse client base, including both regular and one-time customers. - With a robust presence in South India, the training institute boasts 20 years of experience and has recently expanded to include microbiology testing services initiated two years ago. - The laboratory collaborates with several small-scale industries throughout Bangalore, enhancing practical exposure for their trainees. - Each month, the institute educates between 20 to 30 students, contributing to the growth of skilled professionals in the biotechnology and microbiology fields. - Renowned for its quality service, the organization maintains a Google listing with a 4.4 rating and holds ISO, GST, and MSME certifications, affirming its commitment to industry standards.

Clinical research facility for lease, spanning an expansive 20,000 sq ft, located in MIDC Industrial Area. - Fully equipped with advanced research infrastructure including 7 LCMS/MS and multiple deep freezers. - Facility includes more than 70 beds, catering to extensive clinical studies. - Approved by both DCGI and USFDA, ensuring compliance with top global standards. - In-house canteen available, enhancing convenience for long-term research projects. - Tenants have the flexibility to continue the existing business or repurpose the facility for different business ventures. - Property valued at approximately $2.3 million, excluding machinery and furnishings, providing significant value. - Open to infrastructure modifications to suit the lessee's requirements, ensuring versatile utility while maintaining core structure integrity. - The whole facility and the associated assets are completely owned by the business. - The promoter is US-based, but the rest of the directors and business operations are based in Navi Mumbai.

Established as a premier Preclinical Contract Research Organisation, the company is GLP certified and ISO/IEC 17025:2017 accredited, ensuring high standards of quality. - Over the past decade, the company has successfully served over 300 clients, demonstrating a solid track record in the preclinical research sector with a focus on global markets. - Revenue generation is driven by conducting specialized studies on clients' products, showcasing the organisation's expertise and relevance in the current market. The profit margins are varying and constantly growing. - The firm boasts a diverse client base spread across the globe, highlighting its capability to meet international research demands and compliance standards. - The company holds prestigious AAALAC International and NABL certifications. - Promoted and led by a team of qualified professionals with robust experience in the industry. - Located in Tumkur, the organisation employs a skilled workforce of 120, combining local talent with global research best practices to deliver exceptional service.